Arrowhead Pharmaceuticals ARWR
NASDAQ ARWR
$66.25 +0.79 (+1.21%)
At close: Sep 29, 2026 · 4:00 PM EDT

Arrowhead Pharmaceuticals (ARWR) Total Current Liabilities (2010 - 2026)

Updated

Arrowhead Pharmaceuticals (ARWR) recorded Total Current Liabilities of $283.35 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 45.7% from $194.53 million a year earlier but down 4.0% from the prior quarter.

Analysis

Arrowhead Pharmaceuticals (ARWR) Total Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Arrowhead Pharmaceuticals reported Total Current Liabilities of $195.49 million, up 89.5% from FY2024.

  • Annual Total Current Liabilities has a five-year compound annual growth rate of 36.9% (FY2020 to FY2025).
  • Across earlier fiscal years, Total Current Liabilities came in at $103.17 million in FY2024 (-2.2%), $105.46 million in FY2023 (-24.1%), $138.85 million in FY2022 (-5.2%) and $146.54 million in FY2021 (+260.2%).
  • Quarterly Total Current Liabilities has ranged from $63.72 million in fiscal Q1 2024 to $347.43 million in fiscal Q1 2026 over the past five years.
  • On a year-over-year basis, Total Current Liabilities has increased for seven consecutive quarters, with growth averaging 103.0% over the last eight quarters.
  • Peak year-over-year performance for Total Current Liabilities in the last five years was growth of 446.1% in fiscal Q1 2022, against a decline of 47.8% in fiscal Q1 2024 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $295.22 million (Q2 2026), $347.43 million (Q1 2026) and $195.49 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Arrowhead Pharmaceuticals 9.24 Bn 4.02 Bn - 283.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 283.35 Mn
Mar 31, 2026 295.22 Mn
Dec 31, 2025 347.43 Mn
Sep 30, 2025 195.49 Mn
Jun 30, 2025 194.53 Mn
Mar 31, 2025 220.54 Mn
Dec 31, 2024 93.76 Mn
Sep 30, 2024 103.17 Mn
Jun 30, 2024 96.71 Mn
Mar 31, 2024 65.18 Mn
Dec 31, 2023 63.72 Mn
Sep 30, 2023 105.46 Mn
Jun 30, 2023 70.23 Mn
Mar 31, 2023 87.15 Mn
Dec 31, 2022 122.01 Mn
Sep 30, 2022 138.85 Mn
Jun 30, 2022 128.21 Mn
Mar 31, 2022 138.86 Mn
Dec 31, 2021 137.03 Mn
Sep 30, 2021 146.54 Mn
API Access

Arrowhead Pharmaceuticals Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ARWR&period=max&api_key=YOUR_API_KEY